Cargando…
Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system
BACKGROUND: Prior studies reported survival benefits from early initiation of adjuvant chemotherapy for stage III colon cancer, but this evidence was derived from studies that may be sensitive to time-related biases. Therefore, we aimed to estimate the effect of initiating adjuvant chemotherapy ≤8 o...
Autores principales: | Lu, Yan, Gehr, Aaron W., Meadows, Rachel J., Ghabach, Bassam, Neerukonda, Latha, Narra, Kalyani, Ojha, Rohit P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158363/ https://www.ncbi.nlm.nih.gov/pubmed/35641921 http://dx.doi.org/10.1186/s12885-022-09688-w |
Ejemplares similares
-
Cardiotoxicity among socioeconomically marginalized breast cancer patients
por: Lu, Yan, et al.
Publicado: (2022) -
Smoking cessation and survival among people diagnosed with non-metastatic cancer
por: Barnett, Tracey E., et al.
Publicado: (2020) -
Adjuvant colon cancer chemotherapy: Is there an Indian standard of care?
por: Joshi, Rohit
Publicado: (2013) -
Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer
por: Jeong, Woon Kyung, et al.
Publicado: (2015) -
The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
por: Collienne, Maike, et al.
Publicado: (2020)